937 related articles for article (PubMed ID: 15477635)
61. Adjuvant treatment for young women with early breast cancer.
Balduzzi A; Cardillo A; D'Alessandro C; Colleoni M
Minerva Ginecol; 2007 Oct; 59(5):513-27. PubMed ID: 17912178
[TBL] [Abstract][Full Text] [Related]
62. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
J Clin Oncol; 2005 Aug; 23(22):5178-87. PubMed ID: 15998905
[TBL] [Abstract][Full Text] [Related]
63. Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1996 Nov; 348(9036):1189-96. PubMed ID: 8898035
[TBL] [Abstract][Full Text] [Related]
64. Managing patients on endocrine therapy: focus on quality-of-life issues.
Whelan TJ; Pritchard KI
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1056s-1060s. PubMed ID: 16467124
[TBL] [Abstract][Full Text] [Related]
65. Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now?
Baum M
Eur J Cancer; 2005 Aug; 41(12):1667-77. PubMed ID: 16046117
[TBL] [Abstract][Full Text] [Related]
66. [Questions and answers on adjuvant systemic therapy in breast carcinoma].
Fey MF; Castiglione-Gertsch M
Ther Umsch; 1996 Nov; 53(11):839-46. PubMed ID: 8984689
[TBL] [Abstract][Full Text] [Related]
67. Current status of post-chemotherapy tamoxifen in early breast cancer.
Tolcher AW
Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
[TBL] [Abstract][Full Text] [Related]
68. Adjuvant endocrine therapy for early breast cancer.
Andreetta C; Smith I
Cancer Lett; 2007 Jun; 251(1):17-27. PubMed ID: 17150303
[TBL] [Abstract][Full Text] [Related]
69. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Tang SC
Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
[TBL] [Abstract][Full Text] [Related]
70. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
Nourmoussavi M; Pansegrau G; Popesku J; Hammond GL; Kwon JS; Carey MS
Cancer Treat Rev; 2017 Apr; 55():26-35. PubMed ID: 28288389
[TBL] [Abstract][Full Text] [Related]
71. Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival.
Collichio F; Pandya K
Oncology (Williston Park); 1994 Dec; 8(12):45-52. PubMed ID: 7888312
[TBL] [Abstract][Full Text] [Related]
72. Ovarian histopathology in breast cancer patients receiving tamoxifen.
McGonigle KF; Vasilev SA; Odom-Maryon T; Simpson JF
Gynecol Oncol; 1999 Jun; 73(3):402-6. PubMed ID: 10366467
[TBL] [Abstract][Full Text] [Related]
73. Ovarian ablation for early breast cancer.
Early Breast Cancer Trialists' Collaborative Group
Cochrane Database Syst Rev; 2000; (2):CD000485. PubMed ID: 10796722
[TBL] [Abstract][Full Text] [Related]
74. Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer.
Xue C; Peng R; Cao Y; Wang S; Shi Y; An X; Xu F; Yuan Z
PLoS One; 2016; 11(2):e0148849. PubMed ID: 26866810
[TBL] [Abstract][Full Text] [Related]
75. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.
; Cuzick J; Ambroisine L; Davidson N; Jakesz R; Kaufmann M; Regan M; Sainsbury R
Lancet; 2007 May; 369(9574):1711-23. PubMed ID: 17512856
[TBL] [Abstract][Full Text] [Related]
76. Failure of goserelin ovarian ablation in premenopausal women with breast cancer: two case reports.
Jiménez-Gordo AM; de las Heras B; Zamora P; Espinosa E; González-Barón M
Gynecol Oncol; 2000 Jan; 76(1):126-7. PubMed ID: 10620455
[TBL] [Abstract][Full Text] [Related]
77. [Indications for castration in women treated for breast cancer].
Chapet S; Bougnoux AR; Berger C; Descamps P; Body G; Calais G; Bougnoux P; Le Floch O; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(5):445-50. PubMed ID: 8926344
[TBL] [Abstract][Full Text] [Related]
78. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Bao T; Davidson NE
Breast Cancer Res; 2007; 9(6):115. PubMed ID: 18190722
[TBL] [Abstract][Full Text] [Related]
79. Ovarian ablation for premenopausal early-stage breast cancer: an update.
Celio L; Bajetta E; Toffolatti L; Catena L; Beretta E; Buzzoni R
Tumori; 2000; 86(3):191-4. PubMed ID: 10939596
[TBL] [Abstract][Full Text] [Related]
80. Measuring ovarian function in young cancer survivors.
Su HI
Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
